Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

A Registered Cohort Study on Duchenne Muscular Dystrophy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.

Who May Be Eligible (Plain English)

Who May Qualify: - Beyond 2 years old - Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed - Diagnosis should be supported by muscle biopsy, if no genetic confirmation. Who Should NOT Join This Trial: - Presence of other clinically significant illness Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Beyond 2 years old * Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed * Diagnosis should be supported by muscle biopsy, if no genetic confirmation. Exclusion Criteria: * Presence of other clinically significant illness

Locations (1)

First Affiliated Hospital of Fujian Medical University
Fuzhou, China